Strategies to Reduce the Osteoporosis Treatment Gap
FRAX Flaws and Atlernative Fracture Risk Assessment Tools
Friday, May 8, 2020
1:30 PM – 2:10 PM
Participants should be aware of the following financial/non-financial relationships: Nelson Watts, MD, FACP, CCD, MACE: Disclosure information not submitted.
Learning Objectives:
Discuss relevant clinical considerations when utilizing FRAX in the assessment of fracture risk, including its inherent flaws.
Review alternative fracture risk assessment tools.
